Bloomberg Markets Wrap 12/10: Stocks Drop Ahead of Fed Decision

The video discusses the market's view on inflation, highlighting the expected CPI numbers and bond yield trends. It then shifts focus to Sanofi's stock performance, driven by a strategic pivot towards oncology and rare diseases. Lastly, it analyzes Toll Brothers' stock, affected by disappointing guidance and challenges in the California market.

What was the market reaction to Toll Brothers' first quarter guidance?

What factors are contributing to the range-bound nature of Toll Brothers' stock?